<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0061">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Yee</surname>
    <given-names>CS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xie</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hatsell</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hum</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Murugesh</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Economides</surname>
    <given-names>AN</given-names>
   </name>, 
   <name name-style="western">
    <surname>Loots</surname>
    <given-names>GG</given-names>
   </name>, 
   <name name-style="western">
    <surname>Collette</surname>
    <given-names>NM.</given-names>
   </name>
  </person-group>
  <year>2016</year>
  <article-title>Sclerostin antibody treatment improves fracture outcomes in a type I diabetic mouse model</article-title>. 
  <source>Bone</source>. 
  <volume>82</volume>:
  <fpage>122</fpage>â€“
  <lpage>134</lpage>.
  <pub-id pub-id-type="pmid">25952969</pub-id>
 </mixed-citation>
</ref>
